Contribution of mitochondria and endoplasmic reticulum dysfunction in insulin resistance: Distinct or interrelated roles?

Diabetes and Metabolism

Volumn 41, Issue 5, 2015, Pages 358-368

  Rieusset, J ^a,b  

^a CarMeN   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Endoplasmic reticulum; Insulin resistance; Mitochondria; Mitochondria associated membranes; Type 2 diabetes

Indexed keywords

INSULIN;

CELL ORGANELLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM MEMBRANE; ENDOPLASMIC RETICULUM STRESS; HUMAN; INSULIN RESISTANCE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; BIOLOGICAL MODEL; ENZYMOLOGY; LIVER; LIVER MITOCHONDRION; METABOLISM; MUSCLE MITOCHONDRION; UNFOLDED PROTEIN RESPONSE;

ANIMALS; DIABETES MELLITUS, TYPE 2; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; HUMANS; INSULIN RESISTANCE; LIVER; MITOCHONDRIA; MITOCHONDRIA, LIVER; MITOCHONDRIA, MUSCLE; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; UNFOLDED PROTEIN RESPONSE;

EID: 84947037454     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2015.02.006     Document Type: Review

References (87)

1. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006, 7:85-96.
2. Thiebaud D., Jacot E., DeFronzo R.A., Maeder E., Jequier E., Felber J.P. The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 1982, 31:957-963.
3. Home P.D., Pacini G. Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents. Diabetes Obes Metab 2008, 10:699-718.
4. Copps K.D., White M.F. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 2012, 55:2565-2582.
5. Paz K., Hemi R., LeRoith D., Karasik A., Elhanany E., Kanety H., et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 1997, 272:29911-29918.
6. Mothe I., Van Obberghen E. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem 1996, 271:11222-11227.
7. Morino K., Neschen S., Bilz S., Sono S., Tsirigotis D., Reznick R.M., et al. Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle. Diabetes 2008, 57:2644-2651.
8. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
9. Giorgi C., De Stefani D., Bononi A., Rizzuto R., Pinton P. Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int J Biochem Cell Biol 2009, 41:1817-1827.
10. Martin S.D., McGee S.L. The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim Biophys Acta 2014, 1840:1303-1312.
11. Flamment M., Hajduch E., Ferré P., Foufelle F. New insights into ER stress-induced insulin resistance. Trends Endocrinol Metab 2012, 23:381-390.
12. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009, 119:573-581.
13. Kars M., Yang L., Gregor M.F., Mohammed B.S., Pietka T.A., Finck B.N., et al. Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes 2010, 59:1899-1905.
14. Smith R.A., Murphy M.P. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010, 1201:96-103.
15. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313:1137-1140.
16. Rieusset J. Mitochondria and endoplasmic reticulum: mitochondria-endoplasmic reticulum interplay in type 2 diabetes pathophysiology. Int J Biochem Cell Biol 2011, 43:1257-1262.
17. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
18. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005, 54:8-14.
19. Mogensen M., Sahlin K., Fernström M., Glintborg D., Vind B.F., Beck-Nielsen H., et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007, 56:1592-1599.
20. Phielix E., Schrauwen-Hinderling V.B., Mensink M., Lenaers E., Meex R., Hoeks J., et al. Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 2008, 57:2943-2949.
21. Sparks L.M., Xie H., Koza R.A., Mynatt R., Hulver M.W., Bray G.A., et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 2005, 54:1926-1933.
22. de Wilde J., Mohren R., van den Berg S., Boekschoten M., Dijk K.W., de Groot P., et al. Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice. Physiol Genomics 2008, 32:360-369.
23. Bach D., Naon D., Pich S., Soriano F.X., Vega N., Rieusset J., et al. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 2005, 54:2685-2693.
24. Gastaldi G., Russell A., Golay A., Giacobino J.P., Habicht F., Barthassat V., et al. Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia 2007, 50:2348-2355.
25. Pospisilik J.A., Knauf C., Joza N., Benit P., Orthofer M., Cani P.D., et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 2007, 131:476-491.
26. Quintens R., Singh S., Lemaire K., De Bock K., Granvik M., Schraenen A., et al. Mice deficient in the respiratory chain gene Cox6a2 are protected against high-fat diet-induced obesity and insulin resistance. PLoS One 2013, 8:e56719.
27. Han D.H., Hancock C.R., Jung S.R., Higashida K., Kim S.H., Holloszy J.O. Deficiency of the mitochondrial electron transport chain in muscle does not cause insulin resistance. PLoS One 2011, 6:e19739.
28. Wredenberg A., Freyer C., Sandström M.E., Katz A., Wibom R., Westerblad H., et al. Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem Biophys Res Commun 2006, 350:202-207.
29. Zechner C., Lai L., Zechner J.F., Geng T., Yan Z., Rumsey J.W., et al. Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab 2010, 12:633-642.
30. Toledo F.G., Menshikova E.V., Azuma K., Radiková Z., Kelley C.A., Ritov V.B., et al. Mitochondrial capacity in skeletal muscle is not stimulated by weight loss despite increases in insulin action and decreases in intramyocellular lipid content. Diabetes 2008, 57:987-994.
31. Hoeks J., van Herpen N.A., Mensink M., Moonen-Kornips E., van Beurden D., Hesselink M.K., et al. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 2010, 59:2117-2125.
32. Bonnard C., Durand A., Peyrol S., Chanseaume E., Chauvin M.A., Morio B., et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 2008, 118:789-800.
33. Bravard A., Bonnard C., Durand A., Chauvin M.A., Favier R., Vidal H., et al. Inhibition of xanthine oxidase reduces hyperglycemia-induced oxidative stress and improves mitochondrial alterations in skeletal muscle of diabetic mice. Am J Physiol Endocrinol Metab 2011, 300:E581-E591.
34. Lee H.Y., Choi C.S., Birkenfeld A.L., Alves T.C., Jornayvaz F.R., Jurczak M.J., et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab 2010, 12:668-674.
35. Hokayem M., Blond E., Vidal H., Lambert K., Meugnier E., Feillet-Coudray C., et al. Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients. Diabetes Care 2013, 36:1454-1461.
36. Wei Y., Rector R.S., Thyfault J.P., Ibdah J.A. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J Gastroenterol 2008, 14:193-199.
37. Vial G., Dubouchaud H., Leverve X.M. Liver mitochondria and insulin resistance. Acta Biochim Pol 2010, 57:389-392.
38. Flamment M., Rieusset J., Vidal H., Simard G., Malthièry Y., Fromenty B., et al. J Regulation of hepatic mitochondrial metabolism in response to a high fat diet: a longitudinal study in rats. Physiol Biochem 2012, 68:335-344.
39. Zhang D., Liu Z.X., Choi C.S., Tian L., Kibbey R., Dong J., et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A 2007, 104:17075-17080.
40. Monsénégo J., Mansouri A., Akkaoui M., Lenoir V., Esnous C., Fauveau V., et al. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis. J Hepatol 2012, 56:632-639.
41. Poussin C., Ibberson M., Hall D., Ding J., Soto J., Abel E.D., et al. Oxidative phosphorylation flexibility in the liver of mice resistant to high-fat diet-induced hepatic steatosis. Diabetes 2011, 60:2216-2224.
42. Sunny N.E., Parks E.J., Browning J.D., Burgess S.C. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab 2011, 14:804-810.
43. Takamura T., Misu H., Matsuzawa-Nagata N., Sakurai M., Ota T., Shimizu A., et al. Obesity upregulates genes involved in oxidative phosphorylation in livers of diabetic patients. Obesity (Silver Spring) 2008, 16:2601-2609.
44. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
45. Urano F., Wang X., Bertolotti A., Zhang Y., Chung P., Harding H.P., et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000, 287:664-666.
46. Wang D., Wei Y., Schmoll D., Maclean K.N., Pagliassotti M.J. Endoplasmic reticulum stress increases glucose-6-phosphatase and glucose cycling in liver cells. Endocrinology 2006, 147:350-358.
47. Kimura K., Yamada T., Matsumoto M., Kido Y., Hosooka T., Asahara S., et al. Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation. Diabetes 2012, 61:61-73.
48. Ning J., Hong T., Ward A., Pi J., Liu Z., Cao W. Constitutive role for ERIa-XBP1 signalling pathway in the insulin-mediated hepatic lipogenic program. Endocrinology 2011, 152:2247-2255.
49. Kammoun H.L., Chabanon H., Hainault I., Luquet S., Magnan C., Koike T., et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 2009, 119:1201-1215.
50. Li Y., Ge M., Ciani L., Kuriakose G., Westover E.J., Dura M., et al. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. J Biol Chem 2004, 279:37030-37039.
51. Fu S., Yang L., Li P., Hofmann O., Dicker L., Hide W., et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 2011, 473(7348):528-531.
52. Peter A., Weigert C., Staiger H., Machicao F., Schick F., Machann J., et al. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 2009, 58:1757-1765.
53. Deldicque L., Van Proeyen K., Francaux M., Hespel P. The unfolded protein response in human skeletal muscle is not involved in the onset of glucose tolerance impairment induced by a fat-rich diet. Eur J Appl Physiol 2011, 111:1553-1558.
54. Rieusset J., Chauvin M.A., Durand A., Bravard A., Laugerette F., Michalski M.C., et al. Reduction of endoplasmic reticulum stress using chemical chaperones or Grp78 overexpression does not protect muscle cells from palmitate-induced insulin resistance. Biochem Biophys Res Commun 2012, 417:439-445.
55. Hage Hassan R., Hainault I., Vilquin J.T., Samama C., Lasnier F., Ferré P., et al. Endoplasmic reticulum stress does not mediate palmitate-induced insulin resistance in mouse and human muscle cells. Diabetologia 2012, 55:204-214.
56. Peng G., Li L., Liu Y., Pu J., Zhang S., Yu J., et al. Oleate blocks palmitate-induced abnormal lipid distribution, endoplasmic reticulum expansion and stress, and insulin resistance in skeletal muscle. Endocrinology 2011, 152:2206-2218.
57. Hwang S.L., Li X., Lee J.Y., Chang H.W. Improved insulin sensitivity by rapamycin is associated with reduction of mTOR and S6K1 activities in L6 myotubes. Biochem Biophys Res Commun 2012, 418:402-407.
58. Powell D.J., Turban S., Gray A., Hajduch E., Hundal H.S. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem J 2004, 382(Pt 2):619-629.
59. Hirabara S.M., Curi R., Maechler P. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. J Cell Physiol 2010, 222:187-194.
60. Yuzefovych L., Wilson G., Rachek L. Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress. Am J Physiol Endocrinol Metab 2010, 299:E1096-E1105.
61. Yuzefovych L.V., LeDoux S.P., Wilson G.L., Rachek L.I. Mitochondrial DNA damage via augmented oxidative stress regulates endoplasmic reticulum stress and autophagy: crosstalk, links and signaling. PLoS One 2013, 8:e83349.
62. Shiao Y.J., Balcerzak B., Vance J.E. A mitochondrial membrane protein is required for translocation of phosphatidylserine from mitochondria-associated membranes to mitochondria. Biochem J 1998, 331(Pt 1):217-223.
63. Rizzuto R., Pinton P., Carrington W., Fay F.S., Fogarty K.E., Lifshitz L.M., et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 1998, 280:1763-1766.
64. Bravo R., Vicencio J.M., Parra V., Troncoso R., Munoz J.P., Bui M., et al. Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J Cell Sci 2011, 124(Pt 13):2143-2152.
65. Koo H.J., Piao Y., Pak Y.K. Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals 2012, 20:265-280.
66. Rainbolt T.K., Saunders J.M., Wiseman R.L. Stress-responsive regulation of mitochondria through the ER unfolded protein response. Trends Endocrinol Metab 2014, 25(10):528-537.
67. Egnatchik R.A., Leamy A.K., Jacobson D.A., Shiota M., Young J.D. ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. Mol Metab 2014, 3:544-553.
68. Kozlov A.V., Duvigneau J.C., Miller I., Nürnberger S., Gesslbauer B., Kungl A., et al. Endotoxin causes functional endoplasmic reticulum failure, possibly mediated by mitochondria. Biochim Biophys Acta 2009, 1792:521-530.
69. Lim J.H., Lee H.J., Ho Jung M., Song J. Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance. Cell Signal 2009, 21:169-177.
70. Kuster G.M., Lancel S., Zhang J., Communal C., Trucillo M.P., Lim C.C., et al. Redox-mediated reciprocal regulation of SERCA and Na+ - Ca2+ exchanger contributes to sarcoplasmic reticulum Ca2+ depletion in cardiac myocytes. Free Radic Biol Med 2010, 48:1182-1187.
71. Guo R., Ma H., Gao F., Zhong L., Ren J. Metallothionein alleviates oxidative stress-induced endoplasmic reticulum stress and myocardial dysfunction. J Mol Cell Cardiol 2009, 47:228-237.
72. Friedlander R., Jarosch E., Urban J., Volkwein C., Sommer T. A regulatory link between ER-associated protein degradation and the unfolded-protein response. Nat Cell Biol 2000, 2:379-384.
73. Vance J.E. Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem 1990, 265:7248-7256.
74. Szabadkai G., Bianchi K., Várnai P., De Stefani D., Wieckowski M.R., Cavagna D., et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J Cell Biol 2006, 175:901-911.
75. van Vliet A.R., Verfaillie T., Agostinis P. New functions of mitochondria associated membranes in cellular signaling. Biochim Biophys Acta 2014, 1843:2253-2262.
76. Giorgi C., Ito K., Lin H.K., Santangelo C., Wieckowski M.R., Lebiedzinska M., et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010, 330:1247-1251.
77. Betz C., Stracka D., Prescianotto-Baschong C., Frieden M., Demaurex N., Hall M.N. Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci U S A 2013, 110:12526-12534.
78. Bononi A., Bonora M., Marchi S., Missiroli S., Poletti F., Giorgi C., et al. Identification of PTEN at the ER and MAMs and its regulation of Ca(2+) signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ 2013, 20:1631-1643.
79. de Brito O.M., Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008, 456:605-610.
80. Sebastian D., Hernandez-Alvarez M.I., Segales J., Sorianello E., Munoz J.P., Sala D., et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signalling and is essential for normal glucose homeostasis. Proc Natl Acad Sci U S A 2012, 109:5523-5528.
81. Gan K.X., Wang C., Chen J.H., Zhu C.J., Song G.Y. Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats. World J Gastroenterol 2013, 19:1572-1581.
82. Hagiwara A., Cornu M., Cybulski N., Polak P., Betz C., Trapani F., et al. Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab 2012, 15:725-738.
83. Ye R., Ni M., Wang M., Luo S., Zhu G., Chow R.H., et al. Inositol 1,4,5-trisphosphate receptor 1 mutation perturbs glucose homeostasis and enhances susceptibility to diet-induced diabetes. J Endocrinol 2011, 210:209-217.
84. Tubbs E., Theurey P., Vial G., Bendridi N., Bravard A., Chauvin M.A., et al. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance. Diabetes 2014, 63:3279-3294.
85. Ozcan L., Cristina de Souza J., Harari A.A., Backs J., Olson E.N., Tabas I. Activation of calcium/calmodulin-dependent protein kinase II in obesity mediates suppression of hepatic insulin signaling. Cell Metab 2013, 18:803-815.
86. Anelli T., Bergamelli L., Margittai E., Rimessi A., Fagioli C., Malgaroli A., et al. Ero1a regulates Ca2+ fluxes at the endoplasmic reticulum-mitochondria interface (MAM). Antioxid Redox Signal 2012, 16:1077-1087.
87. Paillard M., Tubbs E., Thiebaut P.A., Gomez L., Fauconnier J., Da Silva C.C., et al. Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury. Circulation 2013, 128:1555-1565.